HIV Infections
📧 Sign up to get email alerts when something new happens for HIV Infections.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-02-21Clinical Trial Update: A Clinical Study of the HIV Drug CPT31 in Healthy Volunteers [Phase 1]
Phase 1 clinical trial of CPT31 in healthy volunteers completed; results posted.
-
EMA approval · 2023-02-20EMA Authorised: Odefsey (emtricitabine;rilpivirine hydrochloride;tenofovir alafenamide) — Gilead Sciences Ireland UC
EMA has authorised Odefsey (emtricitabine; rilpivirine hydrochloride; tenofovir alafenamide) for HIV infections.
-
CLINICAL_TRIALS trial_result · 2023-02-13Clinical Trial Update: The Pharmacokinetics, Safety, and Tolerability of Abacavir/Dolutegravir/Lamivudine Dispersible and Immediate Release Tablets in HIV-1-Infected Children Less Than 12 Years of Age [Phase 1, Phase 2]
Phase 1/2 trial evaluating pharmacokinetics, safety, and tolerability of abacavir/dolutegravir/lamivudine dispersible and immediate-release …
-
CLINICAL_TRIALS trial_result · 2023-02-03Clinical Trial Update: Evaluating the Safety of and Adherence to a Vaginal Matrix Ring Containing Dapivirine and Oral Emtricitabine/Tenofovir Disoproxil Fumarate in an Adolescent and Young Adult Female Population [Phase 2]
Phase 2 trial assessing safety and adherence of a vaginal ring with dapivirine plus oral emtricitabine/tenofovir disoproxil fumarate in adol…
-
EMA withdrawal · 2023-02-03EMA Expired: Darunavir Krka d.d. (darunavir) — KRKA, d.d., Novo mesto
The EMA lists Darunavir Krka d.d. (darunavir) as expired, indicating cessation of its marketing authorization in the EU.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-12-19Clinical Trial Update: Coaching for HCV and HIV [NA]
A completed clinical trial update on coaching for Hepatitis C and HIV infections; results posted in December 2022.
-
CLINICAL_TRIALS trial_result · 2022-12-16Clinical Trial Update: Phase 3 Safety and Effectiveness Trial of Dapivirine Vaginal Ring for Prevention of HIV-1 in Women [Phase 3]
Phase 3 trial assessing the safety and effectiveness of the dapivirine vaginal ring for HIV-1 prevention in women has completed; results pos…
-
CLINICAL_TRIALS trial_result · 2022-11-22Clinical Trial Update: Health and Justice: A Continuum of Care for HIV and SU for Justice-Involved Young Adults (PHASE 2) [NA]
Phase 2 clinical trial update for a care continuum program integrating HIV treatment and substance use/disorder services among justice-invol…
-
CLINICAL_TRIALS research · 2022-11-02Clinical Trial Update: Peer-Driven Intervention to Enroll Minorities/Women in HIV/AIDS Clinical Trials (the ACT2 Project) [Phase 2]
Phase 2 clinical trial update on a peer-driven intervention to enroll minorities and women in HIV/AIDS trials (the ACT2 Project) completed.
-
CLINICAL_TRIALS trial_result · 2022-10-19Clinical Trial Update: Safety and Efficacy Trial of a Dapivirine Vaginal Matrix Ring in Healthy HIV-Negative Women [NA]
A completed clinical trial evaluating safety and efficacy of a dapivirine vaginal matrix ring in HIV-negative women, with results posted.
-
CLINICAL_TRIALS trial_result · 2022-10-03Clinical Trial Update: (mo)BETTA Trial in Transwomen for Optimization of ART [Phase 4]
Phase 4 clinical trial update for the moBETTA trial in transwomen for optimization of ART, terminated with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-09-22Clinical Trial Update: Effectiveness of a Telephone-Delivered Behavioral Treatment to Improve the Quality of Life of Older Adults With HIV [Phase 2, Phase 3]
Phase 2/3 trial assessing a telephone-delivered behavioral treatment to improve quality of life in older adults with HIV and depression; stu…
-
CLINICAL_TRIALS trial_result · 2022-09-19Clinical Trial Update: Functional Cure Study of Anti-PD-L1 Antibody ASC22 in Combination With Chidamide in HIV-infected Patients With Antiviral Suppression [Phase 2]
Phase 2 trial update of ASC22 (anti-PD-L1 antibody) in combination with chidamide for HIV-infected patients with suppressed viral load.
-
CLINICAL_TRIALS trial_result · 2022-08-30Clinical Trial Update: Vicriviroc in HIV-Treatment Experienced Subjects (Study P04889AM8)(COMPLETED) [Phase 3]
Phase 3 trial update for vicriviroc in treatment-experienced HIV patients; study completed.
-
EMA approval · 2022-08-29EMA Authorised: Epivir (lamivudine) — ViiV Healthcare BV
Epivir (lamivudine) has been authorised in the European Union for HIV infections.
-
EMA approval · 2022-08-29EMA Authorised: Combivir (lamivudine;zidovudine) — ViiV Healthcare BV
EMA authorised Combivir (lamivudine and zidovudine) for HIV infections, confirming market approval by ViiV Healthcare BV.
-
CLINICAL_TRIALS trial_result · 2022-08-10Clinical Trial Update: Immune Reconstitution as a Determinant of Adverse Effects to New Antiretroviral Therapy in Persons With Advanced HIV Infection [Phase 4]
Phase 4 trial examining immune reconstitution as a determinant of adverse effects to new antiretroviral therapy in persons with advanced HIV…
-
EMA withdrawal · 2022-07-12EMA Withdrawn: Crixivan (indinavir sulfate ethanolate) — Merck Sharp & Dohme B.V.
Crixivan (indinavir sulfate ethanolate) has been withdrawn from EMA marketing authorization.
-
CLINICAL_TRIALS trial_result · 2022-07-11Clinical Trial Update: Evaluating the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Combinations of Monoclonal Antibodies PGT121, PGDM1400, 10-1074, and VRC07-523LS Administered Via Intravenous Infusion in Healthy, HIV-uninfected Adult Participants [Phase 1]
Phase 1 trial evaluating safety, tolerability, pharmacokinetics, and antiviral activity of monoclonal antibody combinations for HIV preventi…
-
CLINICAL_TRIALS trial_result · 2022-06-08Clinical Trial Update: Efprezimod Alfa (CD24Fc, MK-7110) Administration to Decrease Low-Density Lipoprotein (LDL) and Inflammation in Human Immunodeficiency Virus (HIV) Patients (CALIBER) (MK-7110-003) [Phase 2]
Phase 2 study evaluating Efprezimod Alfa (CD24Fc, MK-7110) to reduce LDL and inflammation in HIV patients; study terminated with posted resu…
-
CLINICAL_TRIALS trial_result · 2022-05-23Clinical Trial Update: Evaluation of Pharmacokinetic Interaction Between GSK3640254 and Caffeine, Metoprolol, Montelukast, Flurbiprofen, Omeprazole, Midazolam, Digoxin, and Pravastatin in Healthy Adults [Phase 1]
Phase 1 pharmacokinetic interaction study evaluating potential interactions between GSK3640254 and several common drugs in healthy adults.
-
CLINICAL_TRIALS trial_result · 2022-05-10Clinical Trial Update: PrEP Implementation for Mothers in Antenatal Care [Phase 4]
A Phase 4 clinical trial update on PrEP implementation for mothers in antenatal care has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-05-10Clinical Trial Update: Medication-assisted Treatment for Injecting Drug Users in Vietnam [Phase 4]
Phase 4 trial update evaluating medication-assisted treatment for people with Opioid Use Disorder, including HIV infections, in Vietnam.
-
CLINICAL_TRIALS trial_result · 2022-04-26Clinical Trial Update: HIV-1-Gag Conserved-Element DNA Vaccine (p24CE) Vaccine Study [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating the HIV-1 Gag conserved-element DNA vaccine (p24CE) has been completed with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-04-25Clinical Trial Update: Evaluating the Safety and Immunogenicity of Env (A,B,C,A/E)/Gag (C) DNA and gp120 (A,B,C,A/E) Protein/GLA-SE HIV Vaccines, Given Individually or Co-administered, in Healthy, HIV-1-Uninfected Adults [Phase 1]
Phase 1 trial evaluating safety and immunogenicity of HIV vaccines (Env/Gag DNA and gp120 protein/GLA-SE), given alone or co-administered, i…